| Download the amazing global Makindo app: ✅ Means NICE/National Guidelines 2026 compliant Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
Related Subjects: |Iron deficiency Anaemia |Haemolytic anaemia |Macrocytic anaemia |Megaloblastic anaemia |Microcytic anaemia |Myelodysplasia |Myelofibrosis |Hereditary Spherocytosis |Hereditary Elliptocytosis |Haemophilia A |Haemophilia B |Haemolytic anaemia |Heme |Globins |Red blood cells |White blood cells |Lymphocytes |Platelets |Cryoprecipitate |Fresh Frozen Plasma |Blood Cell Maturation |Blood film interpretation |Reticulocytes
💡 Key Point: The risk of major bleeding increases substantially when antiplatelet and anticoagulant therapies are combined. Dual and triple therapy should therefore be reserved for clear indications, with regular review of duration and necessity.
| Regimen | Typical Indication | Bleeding Admission Rate per Year |
|---|---|---|
| 💊 Aspirin | Ischaemic heart disease (IHD), stroke prevention, vascular risk | 2.6% |
| 💊 Clopidogrel | Secondary prevention after stroke or acute coronary syndrome (ACS) | 4.6% |
| 💉 Warfarin | Atrial fibrillation (AF), venous thromboembolism (VTE), antiphospholipid syndrome (APL) | 4.3% |
| 💊 Aspirin + Clopidogrel | Post-stent (PCI), dual antiplatelet therapy (DAPT) after ACS | 3.7% |
| 💊 Aspirin + Warfarin | IHD + VTE, mechanical valve, or AF overlap | 5.1% |
| 💊 Clopidogrel + Warfarin | VTE or mechanical valve with concurrent vascular event | 12.3% ⚠️ |
| 💊 Aspirin + Clopidogrel + Warfarin | Triple therapy (e.g. stent + AF + mechanical valve) | 12% ⚠️ |